As we were interested in the role of tTG in AD pathology and in particular Aβ aggregation and accumulation, in the present study we investigated whether the distribution of tTG and in situ activity in these AD mouse models at different stages of Aβ pathology is similar to our observations in human AD cases. The gene discussed is TGM2; the disease is Alzheimer disease.